A new study has found that antimalarial drug hydroxychloroquine(HCQ) helped coronavirus patients to survive better in the hospital. Henry Ford health team in its report asserted that although the study differs from earlier research on HCQ, the team said if the drug is given early it benefits COVID-19 patients.

Hydroxychloroquine helped coronavirus patients to survive better, finds new study

The World Health Organization (WHO) said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after new data and studies showed no benefit.

WHO halts hydroxychloroquine trial for COVID-19 over lack of 'proven benefit'

US Food and Drug Administration(FDA) has withdrawn emergency authorization of hydroxychloroquine(HCQ) and chloroquine (CQ) to treat coronavirus patients. Also Read: Latin America and Caribbean pass 80,000 COVID-19 deaths as global cases top 8 million "It is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19," Denise Hinton, head scientist, FDA, said, adding,"nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risk.

US withdraws emergency authorization of hydroxychloroquine, chloroquine for coronavirus patients

World Health Organization(WHO) chief Tedros Adhanom Ghebreyesus said that after a "temporary pause" clinical trials of the drug hydroxychloroquine will resume. Watch Video: "This decision was taken as a precaution while the safety data were reviewed.

After 'temporary pause', WHO to resume hydroxychloroquine trials

After the World Health Organization(WHO) temporarily stopped the clinical trial of hydroxychloroquine for treatment of coronavirus, the French government banned the treatment on Wednesday.

France stops use of hydroxychloroquine as coronavirus treatment

Anti-malaria drug hydroxychloroquine, which is being touted as the cure for the coronavirus pandemic by several experts, is under limelight for the wrong reasons.

Is hydroxychloroquine a miracle drug or a death pill?

A day after the World Health Organization(WHO) stopped trials of hydroxychloroquine, the Indian Council of Medical Research(ICMR) said today that based on risk-benefit the country's health workers should not be denied the use of HCQ.

Based on risk benefit, we should not deny health workers from using hydroxychloroquine: ICMR

US President Donald Trump has championed the cause of hydroxychloroquine. The anti-malarial pill that's now being stocked up by many countries. With a long way to go for a vaccine.

Will Trump's 'game-changing' hydroxychloroquine complicate battle against COVID-19?

A malaria drug widely touted as a potential cure for COVID-19 showed no benefit against the disease over standard care -- and was in fact associated with more deaths, the biggest study of its kind showed Tuesday.

No benefit, higher death rate for malaria drug in coronavirus study